Exclusive Distribution Agreement Signed for Aloxi® injection in China 2007.08.09

 
(Hong Kong, August 9, 2007) - Lee's Pharmaceutical Holdings Limited "the Group") (GEM) Stock: 8221; Website: www.leespharm.com) announced today that the Group and Helsinn Healthcare SA ("HELSINN"), a privately-owned Swiss pharmaceutical group, has entered into an exclusvie Distribution & Supply Agreement for the registration, distribution and marketing of Aloxi® (palonosetron hydrochloride) in People's Republic of China.
 
  Download  


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD